MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical and genetic heterogeneity in portuguese patients with Hereditary Spastic Paraplegia

I. Cunha, A. Brás, J. Ribeiro, C. Januário (Coimbra, Portugal)

Meeting: 2018 International Congress

Abstract Number: 137

Keywords: Familial neurodegenerative diseases, Spasticity: Clinical features, Spasticity: Genetics

Session Information

Date: Saturday, October 6, 2018

Session Title: Genetics (Non-PD)

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To characterize the demographic, clinical and genetic features of HSP and to define the phenotypic spectrum and genotype-specific differences.

Background: Hereditary spastic paraplegia (HSP) is a wide and heterogeneous group of inherited neurodegenerative and neurodevelopmental disorders in which the main neurological symptoms and signs are lowerlimb spasticity and weakness. According to the clinical phenotype, the HSP are classified in pure or complex forms depending on the presence of other neurological features in addition to spastic paraparesis. The estimated prevalence of HSP in Portugal is 4.1 per 100 000 inhabitants, being spastic paraplegia (SPG) types 4, 3 and 11 the most prevalent.

Methods: We present a cross-sectional study of the clinical and genetic characteristics of a cohort of patients with HSP followed at a tertiary centre in Portugal. Multiple sources of information were used (review of clinical files and active collaboration of neurologists and geneticists). Using the available protocols, including single gene and targeted next generation sequencing (NGS).

Results: A total of 43 patients were identified with HSP, and 48.84% had a confirmed genetic diagnosis. We observed a male predominance (58,14%). The mean age of disease onset was 27.25 years. The family history was suggestive of dominant inheritance in approximately half of the patients, most of them presenting a pure phenotype. We identified several forms of HSP, including thirteen patients with SPG4, four with SPG11and one with SPG3A. The NGS was been performed in patients with no molecular diagnosis and we found one patient with SPG5, one with SPG7 and one with SPG76. Additional clinical features were noted, including ataxia for SPG5 and dysarthria and pes cavus for SPG7.

Conclusions: The developmentof genetic techniques brought new possibilities for precise diagnosis and targeted NGS may be a useful method to screen for mutations in multiple genes associated with HSP.

To cite this abstract in AMA style:

I. Cunha, A. Brás, J. Ribeiro, C. Januário. Clinical and genetic heterogeneity in portuguese patients with Hereditary Spastic Paraplegia [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-and-genetic-heterogeneity-in-portuguese-patients-with-hereditary-spastic-paraplegia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-genetic-heterogeneity-in-portuguese-patients-with-hereditary-spastic-paraplegia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley